ReviewJournal of neurology2026
Clinical telemonitoring and telerehabilitation of cognition in rare neurological diseases: a scoping review.
Review in Journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundRare neurological diseases often present with severe cognitive impairment but face significant challenges in access to specialized care. Telemonitoring and telerehabilitation are promising approaches to improve the standard of care in common neurological diseases and could prove even more beneficial to patients with rare neurological diseases.
aimTo review the available evidence on the usability and validity of cognitive telemonitoring or telerehabilitation in rare neurological diseases.
methodsWe performed a scoping review, examining all studies published in the last 25 years on both synchronous and asynchronous cognitive telemonitoring or telerehabilitation approaches in rare neurological diseases of adulthood.
resultsActive digital cognitive tests show promising feasibility and validity, especially for people with Frontotemporal Dementia and Huntington's Disease. However, methodological limitations remain, notably the high rate of dropouts for active telemonitoring and limited evidence of cognitive domain-specific sensitivity for passive telemonitoring. Cognitive telerehabilitation is emerging as a feasible and potentially effective approach for primary progressive aphasia. However, other rare neurological diseases still require proper investigation, and the available evidence is still largely preliminary, and is plagued by small sample sizes and heterogeneous methodology, which limits generalizability.
conclusionOur review recognizes the promise of remote approaches in expanding access to both cognitive monitoring and rehabilitation for rare neurological diseases but emphasizes the need for rigorously designed trials to establish clinical utility and best practices. Key unmet needs include improvement of adherence to active telemonitoring, evaluation of clinical validity in reference to gold-standard clinical outcome measures for passive telemonitoring, evaluation of clinical utility via longitudinal studies, evaluation of feasibility across a wider range of disease severity, and technological literacy.
Indexed as
Identifiers
42260139What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.